EFHD2 drives lactate-mediated DNA damage repair and immunosuppression via HMGB1 and HIF-1α to confer radioresistance in colorectal cancer
Yilin Yu, Haixia Wu, Yu Xiao, Jianjian Qiu, Liang Hong, Baihua Yang, Jianmin Wang, Zhiping Wang, Lingdong Shao, Benhua Xu, Junxin Wu · 2026
Read EFHD2 drives lactate-mediated DNA damage repair and immunosuppression via HMGB1 and HIF-1α to confer radioresistance in colorectal cancer by Yilin Yu, Haixia Wu, Yu Xiao, Jianjian Qiu, Liang Hong, Baihua Yang, Jianmin Wang, Zhiping Wang, Lingdong Shao, Benhua Xu, Junxin Wu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13542245.txt.
Description
Yilin Yu and colleagues published a 2026 laboratory study on why some colorectal cancers resist radiotherapy. Working with resistant cancer cell models, patient tissue, and mice, the team traced resistance to a protein called EFHD2. A small regulatory RNA that normally restrains EFHD2 was scarce in resistant cells, and restoring it weakened the cancer's ability to repair radiation damage to its DNA.
EFHD2, chemically tagged by lactate at one key site, partnered with another protein to raise lactate production and steady a low-oxygen response factor. The extra lactate pushed immune cells toward a suppressive state, raised a checkpoint protein that shields tumours, and reduced helpful T cell entry. Silencing EFHD2 while adding immune checkpoint treatment made tumours far more sensitive to radiation in the animal work. The findings point to the EFHD2 pathway as a drug target for resistant rectal and colon cancers.
Catalog record
| CREATOR | Yilin Yu, Haixia Wu, Yu Xiao, Jianjian Qiu, Liang Hong, Baihua Yang, Jianmin Wang, Zhiping Wang, Lingdong Shao, Benhua Xu, Junxin Wu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 64303 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |